Literature DB >> 7053160

Effect of marihuana on intraocular and blood pressure in glaucoma.

J C Merritt, W J Crawford, P C Alexander, A L Anduze, S S Gelbart.   

Abstract

Marihuana inhalation was accompanied by increased heart rate and decreased intraocular and blood pressure in 18 subjects with heterogenous glaucomas. The hypotensive effects appeared in 60 to 90 minutes as the decrease in intraocular pressure (IOP) appeared to follow the decrease in blood pressure. In addition to any local effect, the mechanism of lowered to any local effect, the mechanism of lowered IOP may also involve the decreased pressure perfusing the ciliary body vasculature as a result of the peripheral vasodilatory properties of marihuana. Postural hypotension, tachycardia, palpitations, and alterations in mental status occurred with such frequency as to mitigate against the routine used in the general glaucoma population. Our data indicate that further research should be directed to local means of delivering the ocular hypotensive cannabinoid to the glaucomatous eye.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7053160     DOI: 10.1016/s0161-6420(80)35258-5

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  26 in total

Review 1.  Use of herbal medicines and nutritional supplements in ocular disorders: an evidence-based review.

Authors:  Justin T Wilkinson; Frederick W Fraunfelder
Journal:  Drugs       Date:  2011-12-24       Impact factor: 9.546

Review 2.  Glaucoma blindness in African Americans: have 55 years of therapies, technologies, and talent altered blindness rates?

Authors:  J C Merritt
Journal:  J Natl Med Assoc       Date:  1996-12       Impact factor: 1.798

Review 3.  Therapeutic Benefit of Smoked Cannabis in Randomized Placebo-Controlled Studies.

Authors:  Lynneice L Bowen; Aimee L McRae-Clark
Journal:  Pharmacotherapy       Date:  2017-12-18       Impact factor: 4.705

4.  Synthesis and evaluation of potent and selective MGL inhibitors as a glaucoma treatment.

Authors:  Shakiru O Alapafuja; Michael S Malamas; Vidyanand Shukla; Alexander Zvonok; Sally Miller; Laura Daily; Girija Rajarshi; Christina Yume Miyabe; Honrao Chandrashekhar; JodiAnne Wood; Sergiy Tyukhtenko; Alex Straiker; Alexandros Makriyannis
Journal:  Bioorg Med Chem       Date:  2018-11-03       Impact factor: 3.641

Review 5.  Glaucoma, hypertension, and marijuana.

Authors:  J C Merritt
Journal:  J Natl Med Assoc       Date:  1982-08       Impact factor: 1.798

Review 6.  The endocannabinoid system as an emerging target of pharmacotherapy.

Authors:  Pál Pacher; Sándor Bátkai; George Kunos
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

Review 7.  Pharmacokinetics and pharmacodynamics of cannabinoids.

Authors:  Franjo Grotenhermen
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

8.  Delta-9-tetrahydrocannabinol (THC) in the treatment of end-stage open-angle glaucoma.

Authors:  Allan J Flach
Journal:  Trans Am Ophthalmol Soc       Date:  2002

9.  Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants.

Authors:  A J Hampson; M Grimaldi; J Axelrod; D Wink
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

Review 10.  Medical marijuana.

Authors:  J B Marmor
Journal:  West J Med       Date:  1998-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.